RGS
Pharmaceuticals, Biotechnology & Life Sciences
Regeneus
- Short interest
- 0.02%
- as of 6 Feb 2020
- Reported shorts
- 60.2K
- Shares on issue
- 277.825M
Regeneus (RGS) company profile
Profile, insiders and operations
Director trades
No director trades found
RGS intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required